February 2020 – PHAGElogist

Safety of phage therapy in patients

Researchers are looking into the potential of phage therapy to combat antibiotic resistance, with recent work suggesting there are no adverse reactions when given to patients with blood infections. New…

Bacteriophage Market

The global bacteriophage market was valued at US$ 567.9 million in 2017 and increased to CAGR by 3.9 per cent from 2018 to 2026. Market InsightsBacteriophages or phages have recently…

Controlled Phage Therapy

A growing concern in health care, antibiotic resistance weakens our ability to treat common infectious diseases. With antibiotics becoming less effective, researchers are looking into possible alternative treatment methods, including…

Mycobacteriophage ‘Is it a solution’?

6 Feb 202021 Mar 2020

The resurgence of tuberculosis and emergence of drug resistant disease has stimulated fresh research into mycobacteriophage. Studies are currently underway to develop phage-based tools for therapeutic and diagnostic use. Our…

Phage Therapy May Combine Efficacy and Convenience

Bringing to bear decades of experience as a researcher of phage biology, Carl R. Merril, MD, is working to realize the therapeutic promise of phages, the viruses that infect bacteria.…